Signet Therapeutics empowers targeted cancer drug discovery and development using novel disease models.
Signet
Close
AI/Computing-Driven TherapeuticsBiotechnology
Targeted cancer drugs and cell-based organoid development
Haisheng Zhang
Founder and CEO
Favorite Innovator
Reinhold Niebuhr